Multidrug -or Carbapenem-resistant Gram-negative Infections: Efficacy and Safety Assessment of Siderophore Cephalosporin Cefiderocol, Highlighting Infection-causative bacterial analysis in Japan -MUSASHI study
Not Applicable
- Conditions
- Infections
- Registration Number
- JPRN-UMIN000053214
- Lead Sponsor
- Shionogi & Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who used cefidrocol for other indications than in the package insert Patients who have received Cefidelocol for less than 72 hours
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Characteristics of patients treated with cefiderocol
- Secondary Outcome Measures
Name Time Method